Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Edouard Auclin

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
European Journal of Cancer (Oxford, England : 1990)|March 24, 2023
Biomarkers of response to immunotherapy in early stage non-small cell lung cancerMatthieu Roulleaux Dugage, Víctor Albarrán-Artahona, Juan Carlos Laguna, et al.
Bulletin Du Cancer|August 16, 2017
[The breakthrough of personalized medicine, new hopes and new challenges]Ronan Flippot, Christophe Massard, Edouard Auclin, et al.
Future Oncology (London, England)|January 19, 2021
Cabazitaxel schedules in metastatic castration-resistant prostate cancer: a reviewCedric Pobel, Edouard Auclin, Adrien Procureur, et al.
Nature Communications|July 2, 2025
Different tumour-resident memory T-cell subsets regulate responses to anti-PD-1 and anti-CTLA-4 cancer immunotherapiesIsabelle Damei, Aziza Caidi, Edouard Auclin, et al.
British Journal of Cancer|July 13, 2019
Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trialEdouard Auclin, Thierry André, Julien Taieb, et al.
Critical Reviews in Oncology/Hematology|September 10, 2022
Prognostic scores including peripheral blood-derived inflammatory indices in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitorsSara Elena Rebuzzi, Arsela Prelaj, Alex Friedlaender, et al.
Bulletin Du Cancer|March 11, 2023
[Collecting duct carcinoma and renal medullary carcinoma in the age of new therapies]Zoé Guillaume, Yves Allory, Edouard Auclin, et al.
Translational Lung Cancer Research|July 23, 2021
Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancerBoris Duchemann, Jordi Remon, Marie Naigeon, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2019
Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre studyClaire Gallois, Pascal Artru, Astrid Lièvre, et al.
Clinics and Research in Hepatology and Gastroenterology|March 4, 2021
Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter studyClaire Gallois, Camille Bourillon, Edouard Auclin, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
European Journal of Cancer (Oxford, England : 1990)|March 24, 2023
Biomarkers of response to immunotherapy in early stage non-small cell lung cancerMatthieu Roulleaux Dugage, Víctor Albarrán-Artahona, Juan Carlos Laguna, et al.
Bulletin Du Cancer|August 16, 2017
[The breakthrough of personalized medicine, new hopes and new challenges]Ronan Flippot, Christophe Massard, Edouard Auclin, et al.
Future Oncology (London, England)|January 19, 2021
Cabazitaxel schedules in metastatic castration-resistant prostate cancer: a reviewCedric Pobel, Edouard Auclin, Adrien Procureur, et al.
Nature Communications|July 2, 2025
Different tumour-resident memory T-cell subsets regulate responses to anti-PD-1 and anti-CTLA-4 cancer immunotherapiesIsabelle Damei, Aziza Caidi, Edouard Auclin, et al.
British Journal of Cancer|July 13, 2019
Association of post-operative CEA with survival and oxaliplatin benefit in patients with stage II colon cancer: a post hoc analysis of the MOSAIC trialEdouard Auclin, Thierry André, Julien Taieb, et al.
Critical Reviews in Oncology/Hematology|September 10, 2022
Prognostic scores including peripheral blood-derived inflammatory indices in patients with advanced non-small-cell lung cancer treated with immune checkpoint inhibitorsSara Elena Rebuzzi, Arsela Prelaj, Alex Friedlaender, et al.
Bulletin Du Cancer|March 11, 2023
[Collecting duct carcinoma and renal medullary carcinoma in the age of new therapies]Zoé Guillaume, Yves Allory, Edouard Auclin, et al.
Translational Lung Cancer Research|July 23, 2021
Current and future biomarkers for outcomes with immunotherapy in non-small cell lung cancerBoris Duchemann, Jordi Remon, Marie Naigeon, et al.
European Journal of Cancer (Oxford, England : 1990)|August 16, 2019
Evaluation of two nutritional scores' association with systemic treatment toxicity and survival in metastatic colorectal cancer: an AGEO prospective multicentre studyClaire Gallois, Pascal Artru, Astrid Lièvre, et al.
Clinics and Research in Hepatology and Gastroenterology|March 4, 2021
Skeletal muscle loss during chemotherapy and its association with survival and systemic treatment toxicity in metastatic colorectal cancer: An AGEO prospective multicenter studyClaire Gallois, Camille Bourillon, Edouard Auclin, et al.
Pageof 9